Research & development decreased 37.7%
Research & development changed -37.7% from the comparable as-filed period.
$69.0M→$43.0M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →LVS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue decreased 0.7%
Revenue changed -0.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$3.2B→$3.2B3 prior comparisons
Selling, general & administrative increased 13.4%
Selling, general & administrative changed +13.4% from the comparable as-filed period.
$292.0M→$331.0M3 prior comparisons
Inventory / revenue moved 20 bp higher
Inventory / revenue changed +20 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
1.26%→1.46%3 prior comparisons
Cash & equivalents decreased 2.1%
Cash & equivalents changed -2.1% from the comparable as-filed period.
$3.5B→$3.4B2 prior comparisons
Stock-based compensation decreased 11.8%
Stock-based compensation changed -11.8% from the comparable as-filed period.
$17.0M→$15.0M3 prior comparisons
SBC / revenue moved 6 bp lower
SBC / revenue changed -6 basis points from the comparable as-filed period.
0.54%→0.48%3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.